期刊文献+

乳腺癌和癌旁组织雌激素受体β亚型构成比分析

Ratio analysis of ERβ isoforms in paired cancerous and adjacent normal breast tissues
原文传递
导出
摘要 目的 探讨乳腺癌和癌旁组织中雌激素受体(ER)β亚型构成比变化.方法 收集87例乳腺癌患者癌和癌旁组织,采用实时荧光定量聚合酶链反应定量测定成对组织中ERβ亚型(ERβ 1、ERβ2和ERβ5)相对表达水平,最终获得各亚型在癌变中的比例.结果 癌组织中ERβ 1、ERβ2和ERβ5的表达水平均较癌旁组织低(P=0.00).在癌组织和癌旁组织,ERβ5在3种主要亚型中所占阳性比例均最高(54.02%和75.84%),尤以癌旁组织为甚,而ERβ 1阳性比例均最低(6.77%和9.74%).ERβ 1和ERβ2在癌旁组织中阳性比例低于癌组织(Z=-2.24,P=0.025和Z=-4.85,P<0.01),而ERβ5在癌旁组织中阳性比例明显高于癌组织(Z=-5.32,P<0.01).结论 乳腺癌变过程中ERβ各亚型表达水平均明显下调,但下调幅度差异显著,亚型构成比变化明显,提示ERβ各亚型在癌变过程中表达调控的差异性机制将成为乳腺癌发病机制研究新的突破口. Objective To illustrate the composition ratio of ERβ isoforms in paired cancerous and adjacent normal tissues from breast cancer patients.Methods Eighty-seven pairs of cancerous and adjacent normal tissues were obtained from breast cancer patients.RT-qPCR was used to determine the relative mRNA expression levels of ERβ isoforms (ER[β1,ERβ2 and ERβ5),and the composition ratios of ERβ isoforms were analyzed.Results The expression levels of all tested ERβ isoforms (ERβ1,ERβ2 and ERβ5) in breast cancer tissues were much lower than those in adjacent normal breast tissues (P 〈 0.01).Isoform ratio analysis showed that ERβ5 was the dominant isoform in both cancerous and adjacent normal tissues with a positive detection rate of 54.02 % and 75.84 %,respectively.Meanwhile,ERβ1 had the lowest detection rate (9.74 % and 6.77 % in cancerous and adjacent normal tissues,respectively).The positive rates for both ERβ1 and ERβ2 were much lower in adjacent normal tissues than those in cancer tissues (Z =-2.24,P =0.025 and Z =-4.85,P 〈 0.01,separately),while more cancerous tissues were ERβ5-positive in comparison to adjacent normal tissues (Z =-5.32,P 〈 0.01).Conclusions The expression levels of all the ERβ isoforms are differentially down-regulated with significant alterations in their composition ratios during breast carcinogenesis.Further understanding on molecular mechanisms underlying the differential down-regulation of ER[β isoforms will shed new light on breast carcinogenesis.
出处 《肿瘤研究与临床》 CAS 2014年第4期217-219,共3页 Cancer Research and Clinic
关键词 乳腺肿瘤 雌激素受体Β 蛋白质亚型 构成比 Breast neoplasms Estrogen receptor beta Protein isoforms Composition rate
  • 相关文献

参考文献10

  • 1Green CA,Peter MB,Speirs V,et al.The potential role of ER beta isoforms in the clinical management of breast cancer[J].Histopathology,2008,53:374-380.
  • 2Guo JL,Xu CY,Jiang ZN,et al.Estrogen receptor beta variants mRNA expressions in gastric cancer tissues and association with clinicopathologic parameters[J].Hepatogastroenterology,2010,57:1584-1588.
  • 3Murphy LC,Leygue E.The role of estrogen receptor-β in breast cancer[J].Semin Reprod Med,2012,30:5-13.
  • 4Leung YK,Mak P,Hassan S,et al.Estrogen receptor (ER)-beta isoforms:a key to understanding ER-beta signaling[J].Proc Nati Acad Sci U S A,2006,103:13162-13167.
  • 5Liu GJ,Wu YS,Brenin D,et al.Development of a high sensitivity,nested Q-PCR assay for mouse and human aromatase[J].Breast Cancer Res Treat,2008,111:343-351.
  • 6Moore JT,McKee DD,Slentz-Kesler K,et al.Cloning and characterization of human estrogen receptor beta isoforms[J].Biochem Biophys Res Commun,1998,247:75-78.
  • 7O'Neill PA,Davies MP,Shaaban AM,et al.Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifentreated post-menopausal breast cancers[J].Br J Cancer,2004,91:1694-1702.
  • 8Davies MP,O'Neill PA,Innes H,et al.Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1,ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer[J].J Mol Endocrinol,2004,33:773-782.
  • 9Palmieri C,Lam EW,Mansi J,et al.The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survival[J].Clin Cancer Res,2004,10:2421-2428.
  • 10Leygue E,Dotzlaw H,Watson PH,et al.Expression of estrogen receptor beta1,beta2,and beta5 messenger RNAs in human breast tissue[J].Cancer Res,1999,59:1175-1179.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部